These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37277329)
1. Estimating the impact of COVID-19 vaccine inequities: a modeling study. Gozzi N; Chinazzi M; Dean NE; Longini IM; Halloran ME; Perra N; Vespignani A Nat Commun; 2023 Jun; 14(1):3272. PubMed ID: 37277329 [TBL] [Abstract][Full Text] [Related]
2. Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study. Gozzi N; Chinazzi M; Dean NE; Longini IM; Halloran ME; Perra N; Vespignani A medRxiv; 2022 Nov; ():. PubMed ID: 36415459 [TBL] [Abstract][Full Text] [Related]
3. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries. Duroseau B; Kipshidze N; Limaye RJ Front Public Health; 2022; 10():1087138. PubMed ID: 36711400 [TBL] [Abstract][Full Text] [Related]
4. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. Savinkina A; Bilinski A; Fitzpatrick M; Paltiel AD; Rizvi Z; Salomon J; Thornhill T; Gonsalves G BMJ Open; 2022 Sep; 12(9):e061752. PubMed ID: 36100306 [TBL] [Abstract][Full Text] [Related]
5. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran. Ghafari M; Hosseinpour S; Rezaee-Zavareh MS; Dascalu S; Rostamian S; Aramesh K; Madani K; Kordasti S BMC Med; 2023 Nov; 21(1):429. PubMed ID: 37953291 [TBL] [Abstract][Full Text] [Related]
6. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318 [TBL] [Abstract][Full Text] [Related]
7. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study. Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864 [TBL] [Abstract][Full Text] [Related]
8. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020-2021. Hasan Q; Elfakki E; Fahmy K; Mere O; Ghoniem A; Langar H; Musa N; Attia R; Othman MM; Samhouri D; Chaudhri I; Abubakar A; Hajjeh R; Hutin YJ BMJ Glob Health; 2022 Jun; 7(Suppl 4):. PubMed ID: 35764354 [TBL] [Abstract][Full Text] [Related]
10. COVAX and equitable access to COVID-19 vaccines. Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037 [TBL] [Abstract][Full Text] [Related]
11. Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries. Liu Y; Procter SR; Pearson CAB; Montero AM; Torres-Rueda S; Asfaw E; Uzochukwu B; Drake T; Bergren E; Eggo RM; Ruiz F; Ndembi N; Nonvignon J; Jit M; Vassall A BMC Med; 2023 Mar; 21(1):85. PubMed ID: 36882868 [TBL] [Abstract][Full Text] [Related]
12. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries. Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685 [TBL] [Abstract][Full Text] [Related]
13. Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data. Boing AF; Boing AC; Barberia L; Borges ME; Subramanian SV Vaccine; 2023 Jun; 41(26):3937-3945. PubMed ID: 37221119 [TBL] [Abstract][Full Text] [Related]
14. Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach. de Oliveira BRB; da Penha Sobral AIG; Marinho MLM; Sobral MFF; de Souza Melo A; Duarte GB Int J Equity Health; 2021 Aug; 20(1):183. PubMed ID: 34391416 [TBL] [Abstract][Full Text] [Related]
15. Anatomy of the first six months of COVID-19 vaccination campaign in Italy. Gozzi N; Chinazzi M; Davis JT; Mu K; Pastore Y Piontti A; Ajelli M; Perra N; Vespignani A PLoS Comput Biol; 2022 May; 18(5):e1010146. PubMed ID: 35613248 [TBL] [Abstract][Full Text] [Related]
16. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908 [TBL] [Abstract][Full Text] [Related]
17. Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19. Patenaude B; Ballreich J BMC Public Health; 2022 Sep; 22(1):1792. PubMed ID: 36131266 [TBL] [Abstract][Full Text] [Related]
18. Measuring income-associated inequalities in COVID-19 vaccination on a global scale: a modeling study. Amimo F; Magit A J Public Health Policy; 2023 Sep; 44(3):449-463. PubMed ID: 37604927 [TBL] [Abstract][Full Text] [Related]
19. Global Vaccine Access Demands Combating Both Inequity And Hesitancy. Hotez PJ Health Aff (Millwood); 2023 Dec; 42(12):1681-1688. PubMed ID: 38048497 [TBL] [Abstract][Full Text] [Related]
20. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. So AD; Woo J BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]